Atul Healthcare to acquire 50% stake in Valsad Institute of Medical Sciences

Image
Capital Market
Last Updated : Oct 04 2022 | 2:31 PM IST
Atul announced that its wholly owned subsidiary, Atul Healthcare has entered into a binding shareholders' agreement with Valsad Institute of Medical Sciences (VIMS) and its existing shareholders which comprise medical doctors and their relatives / associates.

The Agreement executed on 04 October 2022 provides for acquisition of 13,50,000 equity shares of Rs 100 each constituting 50% of the total equity share capital at an issue price of Rs 166.67 per equity share of VIMS by AHCL and other terms and conditions.

Atul will be investing in the said equity shares of AHCL to complete the above transaction.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 04 2022 | 2:12 PM IST

Next Story